In radiotherapy-treated glioblastoma, anti-PD-1 treatment after receiving radiotherapy leads to a selective increase of highly suppressive CD103+ Treg cells with a selective enrichment of lipid metabolism signatures [147]. This evidence concerns the gene PDCD1 and glioblastoma.